Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2024 01:30 ET | Source: CROSSJECT

Crossject annonce son éligibilité au dispositif d’investissement PEA-PME

Le PEA-PME permet aux investisseurs particuliers français d'acheter des titres à des conditions fiscales préférentielles. Dijon, Sept 26, 2024 -- Crossject (ISIN : FR0011716265 ; Euronext : ALCJ),...
September 26, 2024 01:30 ET | Source: CROSSJECT

Crossject announces its eligibility for France’s PEA-PME investment scheme

Enables French retail investors to buy securities under preferential tax conditions Dijon, France Sept 26, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company...
April 02, 2024 12:35 ET | Source: CROSSJECT

La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avril

Dijon, France, 2 avril 2024 – La cotation sur l’action de Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), sur la bourse Euronext reprendra normalement le mercredi 3 avril à 09h00 CET. Le...
April 02, 2024 12:35 ET | Source: CROSSJECT

Crossject trading on Euronext to resume as usual on Wednesday April 3

Dijon, France April 2, 2024 – Trading of the stock of Crossject (ISIN: FR0011716265; Euronext: ALCJ) on the Euronext exchange will resume as normal on Wednesday, April 3 at 09:00 CET. Crossject’s...